MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
CHEBI:188229 chebi:188229 IHCHVBQHVIUSTM-UHFFFAOYSA-N | N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-(hydroxymethyl)-Benzenesulfonamide 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-[4-(hydroxymethyl)phenyl]sulonylurea |
bigg.metabolite:mhglz biggM:mhglz metatlas:MAM03770 IHCHVBQHVIUSTM-UHFFFAOYSA-N | Methyl-hydroxy-gliclazide |
vmhM:mhglz vmhM:mhglz vmhmetabolite:mhglz vmhmetabolite:mhglz IHCHVBQHVIUSTM-UHFFFAOYSA-M | Methyl-hydroxy-gliclazide Extracellular region Hydroxygliclazide Hydroxygliclazide, (cis)-isomer Kidneys N-[4-(Hydroxymethyl)benzenesulfonyl]-n'-{octahydrocyclopenta[c]pyrrol-2-yl}carbamimidate N-[4-(Hydroxymethyl)benzenesulphonyl]-n'-{octahydrocyclopenta[c]pyrrol-2-yl}carbamimidate N-[4-(Hydroxymethyl)benzenesulphonyl]-n'-{octahydrocyclopenta[c]pyrrol-2-yl}carbamimidic acid |
sabiork.compound:32910 sabiorkM:32910 IHCHVBQHVIUSTM-UHFFFAOYSA-N | Methylhydroxygliclazide |
| hmdb:HMDB0014029 IHCHVBQHVIUSTM-UHFFFAOYSA-N | Methylhydroxygliclazide 1-[4-(hydroxymethyl)benzenesulfonyl]-3-{octahydrocyclopenta[c]pyrrol-2-yl}urea 3-{hexahydro-1H-cyclopenta[c]pyrrol-2-yl}-1-[4-(hydroxymethyl)benzenesulfonyl]urea Hydroxygliclazide Hydroxygliclazide, (cis)-isomer N-[4-(Hydroxymethyl)benzenesulfonyl]-n'-{octahydrocyclopenta[c]pyrrol-2-yl}carbamimidate N-[4-(Hydroxymethyl)benzenesulphonyl]-n'-{octahydrocyclopenta[c]pyrrol-2-yl}carbamimidate N-[4-(Hydroxymethyl)benzenesulphonyl]-n'-{octahydrocyclopenta[c]pyrrol-2-yl}carbamimidic acid |
hmdb:HMDB14029 biggM:M_mhglz vmhM:M_mhglz | secondary/obsolete/fantasy identifier |